MUSK PHARMA

Just imagine. Elon Musk at the helm of a pharma company.

Some of us would run a mile; some would have renewed hope for the shakeup of a stale and conservative sector.

Welcome to a thought experiment, diving into unconventional ways of doing business.

This whitepaper scrutinises Musk's radical approach, blending audacity with pragmatism, challenging the cautious pace of industry innovation. Prepare for an insightful journey as we unravel how the ‘siege mentality’ and public provocations could reshape life sciences.

This is a recording of our MUSK PHARMA webinar, hosted by Paul Simms and Rina Newton and broadcast on 11 January 2024.